These results suggest that IGFBP-7 plays a potential role in regulating malignant behavior of head and neck squamous cell carcinoma and may be a novel therapeutic target for determination in the progression of HNSCC patients. Here, IGFBP7 is linked to head and neck squamous cell carcinoma.